The press releases (PRs) on “Nuclear Medicine Equipment Market” added by Big Market Research will enable major enterprises unlocks the real-time data pertaining to the overall industry performance across different regions.
Enquire about discount on report: https://goo.gl/hWsV9C
Nuclear medicine equipment utilize radioactive substances, which are introduced into the body either intravenously or orally in small quantities, to diagnosis and treat various diseases. These equipment create images by capturing the radiation from these radioactive medicines. This technique is used for early diagnosis of a disease, as it tracks the molecular activities within the body. In addition, it is used to examine immediate response to therapeutic interventions.
To Order For a Sample Report Copy, Please Visit: https://goo.gl/j5efho
The global nuclear medicine equipment market is estimated to reach $2,647 million by 2022 from $2,012 million in 2015, growing at a CAGR of 3.9% from 2016 to 2022. Increase in prevalence of cancer, heart-related diseases, and neurological disorders has given rise to the importance of early disease diagnosis, which is expected to positively impact the market growth. The nuclear medicine equipment market is driven by the availability of high-quality equipment, rise in adoption of nuclear medicine equipment, and emergence of innovative & advanced equipment. However, high cost of these equipment and their short half-life, high hospital expense, and high cost related to diagnostic imaging services hinder the market growth.
Enquire about the Complete Report here: https://goo.gl/CzqtpP
The nuclear medicine equipment market is segmented based on product, application, end user, and geography. Based on product, the market is bifurcated into single-photon emission computed tomography (SPECT) and positron emission tomography (PET). SPECT is further segmented into standalone and hybrid SPECT, while PET into standalone and hybrid PET. By application, the market is categorized into cardiology, neurology, oncology, and others. Based on end user, it is classified into hospitals, imaging centers, and academic & research institutes. Geographically, it is analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, Russia, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, and rest of Asia-Pacific), and LAMEA (Brazil, Turkey, Saudi Arabia, Republic of South Africa, Argentina, and rest of LAMEA).
Our strength is in our research analysts who with their proactive approach are able to source best and correct information which can be detrimental in organizations success. We follow six sigma standards leaving no scope for error.
Big Market Research uniqueness lies in its highly ethical reports at economical rates because we value your relationship and growth more than money. Your growth is our aim.